{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:02:12Z","timestamp":1790146932188,"version":"4.0.1"},"reference-count":129,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.tmrv.2018.07.002","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T22:49:28Z","timestamp":1532040568000},"page":"213-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Red Blood Cell Alloimmunization in the Pregnant Patient"],"prefix":"10.1016","volume":"32","author":[{"given":"Jennifer","family":"Webb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2018.07.002_bb0005","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1365-2141.1995.tb05425.x","article-title":"A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion","volume":"91","author":"Heddle","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000462061","article-title":"A prospective study of the incidence of red cell Allo-immunisation following transfusion","volume":"71","author":"Redman","year":"1996","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0015","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1537-2995.2006.00764.x","article-title":"Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?","volume":"46","author":"Schonewille","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/trf.13347","article-title":"Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study)","volume":"56","author":"Schonewille","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/tme.12299","article-title":"British Committee for Standards in Haematology. Guideline for blood grouping and red cell antibody testing in pregnancy","volume":"26","author":"White","year":"2016","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0030","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/00016340802268880","article-title":"Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden","volume":"87","author":"Gottvall","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0035","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/AOG.0000000000002528","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0040","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1537-2995.2007.01625.x","article-title":"Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands","volume":"48","author":"Koelewijn","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0045","series-title":"Technical manual of the American Association of Blood Banks","author":"American Association of Blood Banks","year":"2017"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0050","series-title":"The blood group antigen factsbook","author":"Reid","year":"2012"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tmrv.2016.05.008","article-title":"Hemolytic disease of the fetus and newborn: modern practice and future investigations","volume":"30","author":"Hendrickson","year":"2016","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0060","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/AOG.0000000000002232","article-title":"Practice bulletin no. 181: prevention of Rh D Alloimmunization","volume":"130","author":"B.-O. Committee on Practice","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0065","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1034\/j.1600-0412.2002.810506.x","article-title":"Prognostic value of screening for irregular antibodies late in pregnancy in rhesus positive women","volume":"81","author":"Andersen","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0070","first-page":"1145","article-title":"Is a third-trimester antibody screen in Rh+ women necessary?","volume":"5","author":"Rothenberg","year":"1999","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/14767050601123317","article-title":"Should we continue screening rhesus D positive women for the development of atypical antibodies in late pregnancy?","volume":"20","author":"Adeniji","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0080","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/1471-0528.13816","article-title":"Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme","volume":"123","author":"Slootweg","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0085","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/j.1537-2995.2010.03006.x","article-title":"Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME)","volume":"51","author":"Dajak","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0090","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0029-7844(96)00434-6","article-title":"Female alloimmunization with antibodies known to cause hemolytic disease","volume":"89","author":"Geifman-Holtzman","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0095","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/j.semperi.2011.02.009","article-title":"Diagnostic laboratory technologies for the fetus and neonate with isoimmunization","volume":"35","author":"Geaghan","year":"2011","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/JBM.S80977","article-title":"Occurrence of anti-D alloantibodies among pregnant women in Kasese District, western Uganda","volume":"6","author":"Mbalibulha","year":"2015","journal-title":"J Blood Med"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0105","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-3148.2011.01073.x","article-title":"Maternal red blood cell alloimmunisation in south western Uganda","volume":"21","author":"Natukunda","year":"2011","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2147\/IJWH.S15165","article-title":"Rh isoimmunization in sub-Saharan Africa indicates need for universal access to anti-RhD immunoglobulin and effective management of D-negative pregnancies","volume":"2","author":"Osaro","year":"2010","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(15)61498-2","article-title":"Rhesus disease: a major public health problem","volume":"386","author":"Zipursky","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0120","doi-asserted-by":"crossref","first-page":"F84","DOI":"10.1136\/adc.2009.181172","article-title":"The global burden of Rh disease","volume":"96","author":"Zipursky","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0125","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1471-0528.2008.01984.x","article-title":"Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy","volume":"116","author":"Koelewijn","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0130","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1471-0528.2009.02244.x","article-title":"Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis","volume":"116","author":"Koelewijn","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1537-2995.2006.00708.x","article-title":"Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity","volume":"46","author":"Schonewille","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0140","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/trf.13111","article-title":"Female sex of older patients is an independent risk factor for red blood cell alloimmunization after transfusion","volume":"55","author":"Verduin","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0145","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.tmrv.2011.12.001","article-title":"Is female sex a risk factor for red blood cell alloimmunization after transfusion? A systematic review","volume":"26","author":"Verduin","year":"2012","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0150","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/trf.12624","article-title":"HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies","volume":"54","author":"Schonewille","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0155","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/trf.13648","article-title":"The HLA-DRB1*15 phenotype is associated with multiple red blood cell and HLA antibody responsiveness","volume":"56","author":"Verduin","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0160","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000368995","article-title":"Factors influencing RBC Alloimmunization: lessons learned from murine models","volume":"41","author":"Ryder","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tracli.2012.03.002","article-title":"Effects of genetic, epigenetic, and environmental factors on alloimmunization to transfused antigens: current paradigms and future considerations","volume":"19","author":"Zimring","year":"2012","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0170","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1537-2995.2009.02481.x","article-title":"Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen","volume":"50","author":"Hendrickson","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0175","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1537-2995.2011.03162.x","article-title":"Rapid clearance of transfused murine red blood cells is associated with recipient cytokine storm and enhanced alloimmunogenicity","volume":"51","author":"Hendrickson","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0180","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2007-03-083105","article-title":"Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells","volume":"110","author":"Hendrickson","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0185","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/MOH.0b013e328313695e","article-title":"The role of inflammation in alloimmunization to antigens on transfused red blood cells","volume":"15","author":"Zimring","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0190","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1182\/blood-2013-03-488874","article-title":"Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus\/newborn in a murine model","volume":"122","author":"Stowell","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0195","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/MOH.0000000000000374","article-title":"Prevention of hemolytic disease of the fetus and newborn: what have we learned from animal models?","volume":"24","author":"Cruz-Leal","year":"2017","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0200","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.clinbiochem.2011.03.015","article-title":"Fetal health assessment in utero by laboratory technologies: clinical benefits, risks and controversies","volume":"44","author":"Geaghan","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0205","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1373\/clinchem.2011.166991","article-title":"Fetal laboratory medicine: on the frontier of maternal-fetal medicine","volume":"58","author":"Geaghan","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0210","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1055\/s-0037-1607028","article-title":"Anti-M alloimmunization: management and outcome at a single institution","volume":"7","author":"Stetson","year":"2017","journal-title":"AJP Rep"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21307\/immunohematology-2019-063","article-title":"Comparative evaluation of gel column agglutination and erythrocyte magnetized technology for red blood cell alloantibody titration","volume":"31","author":"Dubey","year":"2015","journal-title":"Immunohematology"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0220","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1537-2995.2012.03793.x","article-title":"Comparison of a gel microcolumn assay with the conventional tube test for red blood cell alloantibody titration","volume":"53","author":"Finck","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0225","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5858\/arpa.2015-0351-OA","article-title":"Impact of uniform methods on Interlaboratory antibody titration variability: antibody titration and uniform methods","volume":"141","author":"Bachegowda","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0230","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/bjh.12965","article-title":"Low anti-RhD IgG-fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn","volume":"166","author":"Kapur","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0235","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/bjh.14438","article-title":"Antigen specificity determines anti-red blood cell IgG-fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn","volume":"176","author":"Sonneveld","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0240","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ajog.2015.01.059","article-title":"Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8: the fetus at risk for anemia\u2014diagnosis and management","volume":"212","author":"p.s.o. Society for Maternal-Fetal Medicine","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0245","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.transci.2014.02.005","article-title":"Fetal blood grouping using cell free DNA\u2014an improved service for RhD negative pregnant women","volume":"50","author":"Bills","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0250","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.transci.2014.02.008","article-title":"Noninvasive fetal RhD genotyping","volume":"50","author":"Clausen","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0255","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/bmj.39518.463206.25","article-title":"Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study","volume":"336","author":"Finning","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0260","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/pd.4419","article-title":"Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark","volume":"34","author":"Clausen","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0265","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/aogs.13191","article-title":"Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland","volume":"96","author":"Haimila","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0270","author":"Norweigan Directorate of Health"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0275","article-title":"Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands","volume":"355","author":"de Haas","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0280","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1111\/vox.12615","article-title":"Vox Sanguinis international forum on application of fetal blood grouping","volume":"113","author":"Daniels","year":"2018","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0285","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0290","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/j.1537-2995.2007.01437.x","article-title":"Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma","volume":"47","author":"Finning","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0295","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/AOG.0000000000001741","article-title":"Circulating cell-free DNA to determine the fetal RHD status in all three trimesters of pregnancy","volume":"128","author":"Moise","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0300","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MOH.0000000000000379","article-title":"Genotyping to prevent Rh disease: has the time come?","volume":"24","author":"van der Schoot","year":"2017","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0305","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1471-0528.1953.tb07683.x","article-title":"The composition of liquor amnii in haemolytic disease of the newborn","volume":"60","author":"Bevis","year":"1953","journal-title":"J Obstet Gynaecol Br Emp"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0310","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0002-9378(16)36265-2","article-title":"Liquor amnil analysis in the management of the pregnancy complicated by resus sensitization","volume":"82","author":"Liley","year":"1961","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0315","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.35.5.815","article-title":"Amniotic fluid spectrophotometry and early delivery in the Management of Erythroblastosis Fetalis","volume":"35","author":"Bowman","year":"1965","journal-title":"Pediatrics"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0320","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0002-9378(11)90767-4","article-title":"Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation: a proposal for clinical management","volume":"168","author":"Queenan","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0325","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200001063420102","article-title":"Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the blood velocity in anemic fetuses","volume":"342","author":"Mari","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0330","first-page":"589","article-title":"Accurate prediction of fetal hemoglobin by Doppler ultrasonography","volume":"99","author":"Mari","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0335","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.semperi.2008.04.007","article-title":"Fetal Doppler: umbilical artery, middle cerebral artery, and venous system","volume":"32","author":"Mari","year":"2008","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0340","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJMoa052855","article-title":"Doppler ultrasonography versus amniocentesis to predict fetal anemia","volume":"355","author":"Oepkes","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0345","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1471-0528.2002.01314.x","article-title":"Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat","volume":"109","author":"Zimmerman","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0350","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajog.2007.10.788","article-title":"The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia","volume":"198","author":"Moise","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0355","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/AOG.0b013e31826d7dc1","article-title":"Management and prevention of red cell alloimmunization in pregnancy: a systematic review","volume":"120","author":"Moise","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0360","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00404-015-3915-7","article-title":"Perinatal survival and procedure-related complications after intrauterine transfusion for red cell alloimmunization","volume":"293","author":"Deka","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0365","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.0001-6349.2004.00394.x","article-title":"Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999","volume":"83","author":"van Kamp","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0370","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000362812","article-title":"Intrauterine blood transfusion: current indications and associated risks","volume":"36","author":"Lindenburg","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0375","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/bmj.330.7502.1255","article-title":"Management of pregnancies with RhD alloimmunisation","volume":"330","author":"Kumar","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0380","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1479-828X.2009.01091.x","article-title":"IVIG - is it the answer? Maternal administration of immunoglobulin for severe fetal red blood cell alloimmunisation during pregnancy: a case series","volume":"49","author":"Connan","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0385","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000111599","article-title":"Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion","volume":"23","author":"Fox","year":"2008","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0390","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1447-0756.1996.tb01071.x","article-title":"Intravenous immunoglobulin as primary therapy or adjuvant therapy to intrauterine fetal blood transfusion: a new approach in the management of severe Rh-immunization","volume":"22","author":"Deka","year":"1996","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0395","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/jpme.1997.25.1.85","article-title":"High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease","volume":"25","author":"Voto","year":"1997","journal-title":"J Perinat Med"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0400","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing Committee of the American Society for apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0405","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/trf.14453","article-title":"Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion","volume":"58","author":"Nwogu","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0410","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.transci.2014.02.026","article-title":"Treatment of D alloimmunization in pregnancy with plasmapheresis and intravenous immune globulin: case report","volume":"51","author":"Fernandez Alba","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0415","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.transci.2015.07.010","article-title":"Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: a case report","volume":"53","author":"Houston","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0420","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jca.20288","article-title":"Early plasmapheresis followed by high-dose gamma-globulin treatment saved a severely rho-incompatible pregnancy","volume":"26","author":"Isojima","year":"2011","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0425","doi-asserted-by":"crossref","first-page":"138.e131","DOI":"10.1016\/j.ajog.2006.10.890","article-title":"Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization","volume":"196","author":"Ruma","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0430","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.transci.2006.07.002","article-title":"A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin","volume":"35","author":"Palfi","year":"2006","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0435","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1111\/trf.13806","article-title":"Autologous intrauterine transfusion in a case of anti-U","volume":"56","author":"Adam","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0440","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1537-2995.2005.00604.x","article-title":"Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku","volume":"45","author":"Lydaki","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0445","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/trf.12331","article-title":"Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature","volume":"54","author":"Al Riyami","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0450","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/(SICI)1520-6661(199905\/06)8:3<141::AID-MFM14>3.0.CO;2-K","article-title":"Use of recombinant human erythropoietin (EPO-alfa) in a mother alloimmunized to the Js(b) antigen","volume":"8","author":"Santolaya-Forgas","year":"1999","journal-title":"J Matern Fetal Med"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0455","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/trf.13977","article-title":"Blood group antigen matching influence on gestational outcomes (AMIGO) study","volume":"57","author":"Delaney","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0460","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/trf.13151","article-title":"The prevalence of anti-K in Canadian prenatal patients","volume":"55","author":"Goldman","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0465","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/trf.12814","article-title":"Provision of KEL1-negative blood to obstetric patients: a 3-year single-institution retrospective review","volume":"55","author":"O'Brien","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0470","doi-asserted-by":"crossref","first-page":"301","DOI":"10.11604\/pamj.2015.21.301.4636","article-title":"Distribution of Kell phenotype among pregnant women in Sokoto, north western Nigeria","volume":"21","author":"Osaro","year":"2015","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0475","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1537-2995.2002.00007.x","article-title":"Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions","volume":"42","author":"Aygun","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0480","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0485","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1537-2995.2012.03796.x","article-title":"Red blood cell alloimmunization in sickle cell disease: prevalence in 2010","volume":"53","author":"Miller","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0490","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1586\/14737159.2015.1086646","article-title":"Considerations of red blood cell molecular testing in transfusion medicine","volume":"15","author":"Svensson","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0495","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tmrv.2014.04.008","article-title":"Red blood cell alloimmunization mitigation strategies","volume":"28","author":"Hendrickson","year":"2014","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0500","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1111\/trf.14212","article-title":"Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease","volume":"57","author":"Gehrie","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0505","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/trf.12250","article-title":"Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients","volume":"54","author":"Kacker","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0510","first-page":"734","article-title":"Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura","volume":"12","author":"Stasi","year":"2010","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0515","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1423-0410.2012.01603.x","article-title":"Pharmacokinetics and safety of roledumab, a novel human recombinant monoclonal anti-RhD antibody with an optimized fc for improved engagement of FCgammaRIII, in healthy volunteers","volume":"103","author":"Yver","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0520","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009617.pub2","article-title":"Anti-D administration after spontaneous miscarriage for preventing rhesus alloimmunisation","author":"Karanth","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0525","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jogc.2017.11.007","article-title":"No. 133-prevention of Rh alloimmunization","volume":"40","author":"Fung","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0530","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1537-2995.2006.00898.x","article-title":"Antenatal administration of Rh-immune globulin causes significant increases in the immunomodulatory cytokines transforming growth factor-beta and prostaglandin E2","volume":"46","author":"Branch","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0535","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/trf.12880","article-title":"Prophylactic anti-D preparations display variable decreases in fc-fucosylation of anti-D","volume":"55","author":"Kapur","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0540","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0887-7963(87)70010-8","article-title":"Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures","volume":"1","author":"Bowman","year":"1987","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0545","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta7040","article-title":"A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative","volume":"7","author":"Chilcott","year":"2003","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0550","first-page":"101","article-title":"Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region","volume":"16","author":"Huchet","year":"1987","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0555","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1471-0528.2004.00243.x","article-title":"A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant","volume":"111","author":"Jones","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0560","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.0041-1132.2003.00632.x","article-title":"Thirty-five years of Rh prophylaxis","volume":"43","author":"Bowman","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tme.12099","article-title":"Anti-D prophylaxis: past, present and future","volume":"24","author":"de Haas","year":"2014","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0570","first-page":"328","article-title":"Current status of immunoprophylaxis with anti-D immunoglobin","volume":"85","author":"Engelfriet","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0575","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000020.pub3","article-title":"Anti-D administration in pregnancy for preventing rhesus alloimmunisation","author":"McBain","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0580","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/ajcp\/aqw051","article-title":"Pathology consultation on patients with a large Rh immune globulin dose requirement","volume":"145","author":"Welsh","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0585","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cyto.10154","article-title":"Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection","volume":"50","author":"Chen","year":"2002","journal-title":"Cytometry"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0590","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/15513815.2016.1209260","article-title":"Flow cytometry in detection of fetal red blood cells and maternal F cells to identify Fetomaternal hemorrhage","volume":"35","author":"Farias","year":"2016","journal-title":"Fetal Pediatr Pathol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0595","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-3148.2012.01143.x","article-title":"Comparison of haemoglobin F detection by the acid elution test, flow cytometry and high-performance liquid chromatography in maternal blood samples analysed for fetomaternal haemorrhage","volume":"22","author":"Chambers","year":"2012","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0600","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.moh.0000245687.09215.c4","article-title":"Detecting fetomaternal hemorrhage by flow cytometry","volume":"13","author":"Dziegiel","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0605","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ajh.22255","article-title":"Detection of fetomaternal hemorrhage","volume":"87","author":"Kim","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0610","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.5858\/arpa.2014-0605-LE","article-title":"Rhesus immune globulin dosing in the obesity epidemic era","volume":"139","author":"Pham","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0615","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5858\/arpa.2016-0286-LE","article-title":"Rhesus immunoglobulin dosage and administration in obese individuals","volume":"141","author":"Woo","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0620","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/blood.V93.1.385","article-title":"Molecular basis of weak D phenotypes","volume":"93","author":"Wagner","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0625","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/trf.12941","article-title":"It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American pathologists transfusion medicine resource committee work group","volume":"55","author":"Sandler","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0630","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/trf.13074","article-title":"Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype","volume":"55","author":"Kacker","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0635","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajog.2006.10.895","article-title":"High additional maternal red cell alloimmunization after rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus","volume":"196","author":"Schonewille","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0640","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2006-934092","article-title":"Prevalence of new maternal alloantibodies after intrauterine transfusion for severe rhesus disease","volume":"23","author":"Watson","year":"2006","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.tmrv.2018.07.002_bb0645","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1111\/trf.13231","article-title":"Extended matched intrauterine transfusions reduce maternal Duffy, Kidd, and S antibody formation","volume":"55","author":"Schonewille","year":"2015","journal-title":"Transfusion"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796318300166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796318300166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T19:04:40Z","timestamp":1661627080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796318300166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":129,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0887796318300166"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2018.07.002","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Red Blood Cell Alloimmunization in the Pregnant Patient","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2018.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}